GeneReach Biotechnology Corp. announced earnings results for the third quarter ended September 30, 2018. For the third quarter, the company announced sales was TWD 43.028 million compared to TWD 35.422 million a year ago. Negative sales was TWD 51,000 compared to Sales of TWD 0 a year ago. Operating income was TWD 1.290 million compared to operating loss of TWD 4.816 million a year ago. Net income was TWD 3.622 million compared to net loss of TWD 5.987 million a year ago. Basic earnings per share was TWD 0.11 compared to basic loss per share of TWD 0.17 a year ago. Diluted earnings per share was TWD 0.06 compared to diluted loss per share of TWD 0.17 a year ago. For the nine months, sales was TWD 131.906 million compared to TWD 117.755 million a year ago. Negative sales was TWD 51,000 compared to Sales of TWD 0 a year ago. Operating income was TWD 12.111 million compared to operating loss of TWD 9.373 million a year ago. Net income was TWD 26.461 million compared to net loss of TWD 18.672 million a year ago. Basic earnings per share was TWD 0.77 compared to basic loss per share of TWD 0.54 a year ago. Diluted earnings per share was TWD 0.7 compared to diluted loss per share of TWD 0.54 a year ago.